Shopping Cart 0
Cart Subtotal
USD 0

Celsion Corp (CLSN)-Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Celsion Corp (CLSN)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Celsion Corp (Celsion) is an oncology company that focuses on developing a portfolio of new cancer treatments, including directed chemotherapies, RNA based therapies and DNA-mediated immunotherapy. The company's three platform technologies including Lysolipid Thermally Sensitive Liposomes (LTSL), TheraPlas and TheraSilence provide the foundation for a wide range of therapeutics for common and difficult-to-treat forms of cancers. Its lead product candidate ThermoDox is a proprietary dosage form of doxorubicin based LTSL technology in a Phase III clinical trial for the treatment of non-resectable hepatocellular carcinoma (HCC) and a Phase II clinical trial for recurrent chest wall (RCW) breast cancer. It is also developing a comprehensive pipeline of targeted therapeutic agents. Celsion is headquartered in Lawrenceville, New Jersey, the US.

Celsion Corp Key Recent Developments

Mar 16,2017: Celsion Reports Year End 2016 Financial Results and Provides Business Update

Nov 10,2016: Celsion Reports Third Quarter 2016 Financial Results

Aug 15,2016: Celsion Reports Second Quarter 2016 Financial Results and Provides Business Update

May 16,2016: Celsion Reports First Quarter 2016 Financial Results and Provides Business Update

Mar 30,2016: Celsion Reports Year End 2015 Financial Results and Provides Business Update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Celsion Corp-Key Facts 5

Celsion Corp-Key Employees 6

Celsion Corp-Key Employee Biographies 7

Celsion Corp-Major Products and Services 8

Celsion Corp-Pharmaceutical Pipeline Products Data 9

Celsion Corp, Pipeline Products by Therapy Area 9

Celsion Corp, Pipeline Products by Development Phase 10

Celsion Corp-History 11

Celsion Corp-Company Statement 14

Celsion Corp-Locations And Subsidiaries 16

Head Office 16

Section 2-Company Analysis 17

Celsion Corp-Business Description 17

Celsion Corp-Corporate Strategy 18

Celsion Corp-SWOT Analysis 19

SWOT Analysis-Overview 19

Celsion Corp-Strengths 19

Celsion Corp-Weaknesses 20

Celsion Corp-Opportunities 21

Celsion Corp-Threats 22

Celsion Corp-Key Competitors 23

Section 3-Company Financial Ratios 24

Financial Ratios-Capital Market Ratios 24

Financial Ratios-Annual Ratios 25

Performance Chart 27

Financial Performance 27

Financial Ratios-Interim Ratios 28

Financial Ratios-Ratio Charts 29

Section 4-Company's Lifesciences Financial Deals and Alliances 30

Celsion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 30

Celsion Corp, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 31

Celsion Corp, Recent Deals Summary 32

Section 5-Company's Recent Developments 33

Mar 16, 2017: Celsion Reports Year End 2016 Financial Results and Provides Business Update 33

Nov 10, 2016: Celsion Reports Third Quarter 2016 Financial Results 36

Aug 15, 2016: Celsion Reports Second Quarter 2016 Financial Results and Provides Business Update 38

May 16, 2016: Celsion Reports First Quarter 2016 Financial Results and Provides Business Update 40

Mar 30, 2016: Celsion Reports Year End 2015 Financial Results and Provides Business Update 42

Section 6-Appendix 44

Methodology 44

Ratio Definitions 44

About GlobalData 48

Contact Us 48

Disclaimer 48


List Of Figure

List of Figures

Celsion Corp, Pipeline Products by Therapy Area 9

Celsion Corp, Pipeline Products by Development Phase 10

Celsion Corp, Performance Chart (2012-2016) 27

Celsion Corp, Ratio Charts 29

Celsion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 30

Celsion Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 31


List Of Table

List of Tables

Celsion Corp, Key Facts 5

Celsion Corp, Key Employees 6

Celsion Corp, Key Employee Biographies 7

Celsion Corp, Major Products and Services 8

Celsion Corp, Number of Pipeline Products by Therapy Area 9

Celsion Corp, Number of Pipeline Products by Development Stage 10

Celsion Corp, History 11

Celsion Corp, Key Competitors 23

Celsion Corp, Ratios based on current share price 24

Celsion Corp, Annual Ratios 25

Celsion Corp, Annual Ratios (Cont...1) 26

Celsion Corp, Interim Ratios 28

Celsion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 30

Celsion Corp, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 31

Celsion Corp, Recent Deals Summary 32

Currency Codes 44

Capital Market Ratios 44

Equity Ratios 45

Profitability Ratios 45

Cost Ratios 46

Liquidity Ratios 46

Leverage Ratios 47

Efficiency Ratios 47

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Tesaro Inc Merck & Co Inc Genentech Inc Bristol-Myers Squibb Company Amgen Inc